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1. Experimental Details 
 
1.1. Synthesis of peptides 
Peptides listed in Table S1 were synthesized by a manual method[1] or using an automated 
synthesizer (Liberty Lite, CEM). In brief, Rink Amide resin (0.71 mmol/g) was prepared by 
swelling in DMF (2 ml) for 20 min, and subjected to coupling cycles, in which the Fmoc protecting 
group was removed with a piperidine solution in DMF (20%, 2 ml) for 10 min, and the resin was 
subsequently washed with DMF (3 x 2 ml, 1 min). Then, a mixture in DMF of Fmoc-a-amino acid 
(4 equiv.), N-HBTU (4 equiv.) and DIEA (4 equiv.) was added to the resin. The coupling 
proceeded under nitrogen flow for 15 mins, and the resin was washed with DMF (3 x 2 ml, 1 min). 
For the automated synthesis, Rink Amide resin (0.05 mmol) was placed in the reaction vessel and 
swollen in DMF. Then, amino acid coupling cycles were performed under nitrogen atmosphere 
involving Fmoc removal with piperidine (20% in DMF), washing with DMF three times, addition 
of coupling mixture (5 equiv. of amino acid, 10 equiv. of DIC, and 10 equiv. of Oxyma), coupling 
reaction assisted with microwave radiation for 5 mins, and three washing cycles.  
 
1.2 Purification and characterization of peptides. 
1.2.1. αSP 
Peptide was purified by preparative high-performance liquid chromatography (HPLC) (Waters 
1525 with a binary pump and a dual wavelength Waters 2489 UV detector) using an Agilent 
Eclipse XDB-C18 column [A = H2O + 0.1% TFA ; B = ACN + 0.1% TFA: 0 min (5% B) to 30 
min (70% B), (88 mg, 45% isolated yield); uHPLC: gradient water-ACN (0.1 % TFA) 0 min (5% 




water overlapped), 4.52 (m, 3 H), 4.5 (m, 3 H, JHH = 6 Hz), 4.38-4.15 (m, 11 H), 3.92-3.45 (m, 11 
H), 3.15-1.80 (m, 48 H), 2.11 (s, 3 H), 1.37 (d, 3 H, JHH = 6 Hz); HR-MS calculated for 
C84H112N18O33S2-: 966.3685, found: 966.3679. 
1.2.2. αSPN 
Peptide was purified by preparative HPLC using an Agilent Eclipse XDB-C18 column [A = H2O 
+ 0.1% TFA ; B = ACN + 0.1% TFA: 0 min (5% B) to 30 min (70% B), (85 mg, 41% isolated 
yield). uHPLC: gradient water-ACN (0.1 % TFA) 0 min (5% B) → 12 min (95% B); 1H NMR 
(300 MHz, D2O, 298 K) δ: 7.08 (m, 6 H), 6.79 (m, 6 H), 4.60-4.50 (m, water overlapped), 4.38-
4.15 (m, 11 H), 3.92-3.45 (m, 11 H), 3.15-1.8 (m, 50 H), 2.11 (s, 3 H), 1.37 (d, 3 H, JHH = 6 Hz); 
HR-MS calculated for C87H117N19O34S22-, 1017.8731, found: 1017.8728. 
1.2.3. αSPC 
Peptide was purified by preparative HPLC using an Agilent Eclipse XDB-C18 column [A = H2O 
+ 0.1% TFA ; B = ACN + 0.1% TFA: 0 min (5% B) to 30 min (70% B), (80 mg, 39% isolated 
yield). uHPLC: gradient water-ACN (0.1 % TFA) 0 min (5% B) → 12 min (95% B); 1H NMR 
(300 MHz, D2O, 298 K) δ: 7.08 (m, 6 H), 6.81 (m, 6 H), 4.75 (m, water overlapped), 4.61 (t, 2 H, 
JH,H = 6 Hz), 4.55-4.24 (m, 11 H), 4.23 (t, 2 H, JH,H = 6 Hz), 3.98-3.46 (m, 6 H), 3.20-1.80 (m, 43 
H), 2.11 (s, 3 H), 1.37 (d, 3 H, JHH = 6 Hz); HR-MS calculated for C87H117N19O34S22-, 1017.8731, 
found: 1017.8728. 
1.2.4. 6EN 
Peptide was purified by preparative HPLC using an Agilent Eclipse XDB-C18 column [A = H2O 
+ 0.1% TFA; B = ACN + 0.1% TFA: 0 min (0% B) to 30 min (95% B), (18 mg, 20% isolated 
yield). uHPLC: gradient water-ACN (0.1 % TFA) 0 min (5% B) → 12 min (95% B); 1H NMR 




JH,H = 9 Hz), 7.32 (s, 1 H), 7.06 (s, 1 H), 4.38-4.11 (m, 7 H), 2.93 (b, 2 H), 2.25 (b, 12 H), 2.00-
1.60 (m, 12 H). 
1.2.5. (4)αSPN, (6)αSPN, (8)αSPN, (10)αSPN, (12)αSPN, (14)αSPN, (tdm)αSP, (tdm)αSPN, (tdm)αSPC, 
(P￫A)αSPN, (Y￫A)αSPN, and (P/Y￫A)αSPN 
Peptide was purified by preparative HPLC using an Agilent Eclipse XDB-C18 column [A = H2O 
+ 0.1% TFA; B = ACN + 0.1% TFA: 0 min (5% B) to 30 min (50% B); uHPLC: gradient water-
ACN (0.1 % TFA) 0 min (5% B) → 12 min (95% B). 
 
1.3. Preparation of aSPN-AuNP  
The aSPN-AuNP conjugates were prepared by incubating the mixture of aSPN (200 µM in 
deionized water, 20 µl) and 20-nm citrate-capped AuNP (Nanovex Biotechnologies, 0.05 mg/ml 
in 2 mM citrate at pH 6.5, 180 µl) overnight at 4oC and removal of excess peptides was performed 
by centrifugation at 16100g for 10 mins at 4oC three times.  
 
1.4. Monolayer adsorption of aSPN -AuNP onto various substrates 
The prepared conjugates were centrifuged and resuspended with 2 µl of 50 mM citrate at pH 4.5, 
and then placed on the ultrasonically pre-cleaned substrates including Si, boron-doped p-type Si, 
SiO2, Au, Ti, glass, PC, and PET. Following incubation at 40oC for 3 hours in a humid chamber, 
the substrates were washed with excess methanol (20%, 4oC) and purged with nitrogen gas. For 
the superlattice formation on mica, the incubation was carried out at either pH 4.75 (30oC), pH 





1.5. Atomic force microscopy (AFM) analysis 
The aSPN-AuNP-adsorbed substrates were examined with AFM (XE-100, Park Systems 
Corporation) under ambient atmosphere at room temperature in a non-contact mode using ACTA 
cantilevers. For analyzing thickness of the layer, each substrate was smoothly scratched with PET 
before the AFM measurement. 
 
1.6. Scanning electron microscope (SEM) analysis 
The conjugate-adsorbed substrates were sputter-coated with a 5-nm-thick layer of platinum, and 
then analyzed with SEM (Zeiss Ultra Plus) at 3.0 kV. 
 
1.7. Circular dichroism (CD) 
CD spectra were obtained with a Jasco J-1100 CD spectrometer at 20 ◦C in a 2 mm light path 
quartz cuvette after substraction of the solvent background signal.  
 
1.8. Computational analysis for isoelectric point (pI) of aSP 
Isoelectric point (pI) of aSPN was obtained by calculation programs provided on the websites of 
INNOVAGEN (https://pepcalc.com).  
 
1.9. NMR spectroscopy 
Secondary chemical shift analysis and side-chain carboxyl pKa determination were performed by 
analyzing a pH titration monitored by 1H-13C HSQC spectra obtained at natural isotope abundance. 
Unambiguous residue assignments were obtained by analyzing 1H-1H TOCSY and NOESY 




samples were freshly dissolved independently from lyophilized powder in 5 mM citrate buffer 
containing 1.5 mM TCEP, pH 4.5. Final peptide concentration was adjusted to 1.5 mM and pH 
was adjusted to the desired value. Data were acquired at 310 K in a 600 MHz Bruker Avance 
spectrometer equipped with a cryoprobe. All samples contained 10 μM DSS (4,4-dimethyl-5-
silapentane-1-sulfonic acid) for chemical shift referencing. Random coil Cα and Cβ chemical shifts 
were generated using the software POTENCI[2] at each of the indicated pH values, 310 K and 
solution ionic strength as calculated using the software Buffer Maker from ChemBuddy. For side-
chain carboxyl pKa determination, Cγ (Glu) or Cβ (Asp) chemical shifts were monitored in the 
same 1H-13C HSQC spectra series.[3] Data were normalized according to: 
(δ13CpH=x – δ13CpH=2.0)/(δ13CpH=6.0  – δ13CpH=2.0) 
The resulting values were fitted to a four-parameter sigmoidal curve using the software Prism to 
obtain the pKa values. 
 
1.10. Dynamic light scattering (DLS) 
Statistical distribution of the hydrodynamic diameters of peptide-AuNPs were obtained with a 
Zetasizer Nano ZSP (Malvern) in either MQ or 50 mM citrate buffer at pH 4.5. 
 
1.11. Chaperone activity of peptides 
Molecular chaperone activity of the peptides was examined according to the procedure previously 
reported.[4,5] Peptide solutions were co-incubated with either alcohol dehydrogenase (ADH) or 
lysozyme at 60oC in 20 mM MES at pH 6.5, and their turbidity was monitored at 405 nm with 
Libra UV/Visible spectrophotometer (Biochrom). The ADH activity was accessed at 340 nm by 




containing 0.2 mM NAD+ and 1 mM ethanol during the incubation at 60oC. For the control 
experiments, wild type human αS protein was prepared according to the protocol described in the 





2. Supporting figures 
 
2.1. Conjugates preparation and adhesion experiments 
 
 





































Figure S1. Optical photographs of colloidal (a) αSPN-AuNP, (b) αSPC-AuNP, and (c) 6EN-AuNP 









Figure S2. Absorption spectra of colloidal solutions of bare AuNPs (black line), αSPN-AuNP (blue 


















Figure S4. SEM images of αSPN-AuNP adsorbed onto silicon substrate after incubation (50 mM 







Figure S5. Photo images of (a) αSPN-AuNP and (b) αSPC-AuNP in 50 mM citrate at pH 4.5 on 




Figure S6. DLS spectra of αSPN-AuNPs (blue line) and αSPC-AuNPs (purple line) in either (top) 
MQ or (bottom) 50 mM citrate at pH 4.5. DLS spectra of bare AuNP (red line) in 2 mM citrate at 
pH 6.5 were provided for comparison. Optical images of the conjugate solutions showing different 
plasmonic colors of αSPN-AuNPs (red) and αSPC-AuNPs (blue) in 50 mM citrate at pH 4.5 are 





Fig S7. SEM images of 6EN-AuNP conjugates on silicon surface after incubation at 40oC for 3 





Figure S8. Images of tips used for pipetting αSPN-AuNP solution in 50 mM citrate at different 













Figure S10. SEM images of αSPN-AuNPs after incubation (40oC) on silicon substrate for 3 hours 






Figure S11. SEM images of serially truncated αSPN-AuNPs adhered onto silicon surface following 








Figure S12. 3 sets of SEM images (1 𝛍m x 1 𝛍m) of serially truncated αSPN-AuNPs adsorbed 
onto silicon substrate after incubating (40oC) for 3 hours in 50 mM citrate buffer at pH 4.5, and 











Figure S13. SEM images of (P￫A)αSPN-AuNP (left) and (Y￫A)αSPN-AuNP (right) deposited onto 
silicon surface after incubation at 40oC for 3 hours in 50 mM citrate (pH 4.5). Amino acids 









Figure S14. SEM images of (a) αSPN-AuNPs and (b) (P/Y￫A)αSPN-AuNPs deposited onto silicon 







Figure S15. SEM images of (a) αSPN-AuNPs, (b) (tdm)αSPN-AuNPs, (c) (P/Y￫A)αSPN-AuNPs 
adhered onto multiple substrates of Si, SiO2, P-type Si, Au, Ti, quartz, PC, PET, or mica after 





Figure S16. AFM 2-D images (10 𝛍m x 10 𝛍m) of αSPN-AuNPs monolayer on different substrates 
of Si, SiO2, boron-doped p-type Si, Ti, and PET. The white lines on the images indicate the location 







Figure S17. pH-Dependent superlattice formation of αSPN-AuNPs single layer on mica substrate. 
SEM images of αSPN-AuNPs deposited onto the mica surface after incubation for 3 hours at 
various pHs varying between 3.75 and 5.00 in 0.25 intervals at different temperatures of 30oC (top 
row), 35oC (middle row), and 40oC (bottom row). The images in a red-lined box show the best 









Figure S18. Sequence of (tdm)αSP (green) and αSP (blue) located in the C-terminal region of αS 







Figure S19. Chaperone activity of αSP. (a) Relative scattering of thermal aggregation of lysozyme 
and ADH in the presence or absence of either (tdm)αSP or αSP accessed with a turbidity assay. (b) 
Relative ADH activity monitored at 340 nm after co-incubating (60oC) with either αS protein, 








Figure S20. SEM images of (tdm)αSPN-AuNPs deposited onto silicon surface after incubating for 3 










Figure S21. SEM images of (a) αSPN-AuNP, (b) (tdm)αSP-AuNP, and (c) (tdm)αSPC-AuNP adsorbed 







2.2. Circular dichroism (CD) of prepared peptides  
 
 
Figure S22. CD spectra of free αSPN (50 µM) in 5 mM citrate at different pH of 3.75 (blue), 4.00 
(orange), 4.25 (gray), 4.50 (yellow), 4.75 (light blue), and 4.50 (green). CD values at 204 nm 








2.3. Characterization of αSP by NMR 
 
 
Figure S23. (a) NMR spectra acquired at pH 4.5 and 310 K, with αSPN resonance assignments. 
On the left panel, a region of the 1H-1H TOCSY spectrum is shown corresponding to the 
correlations between HN and side-chain aliphatic protons. Vertical lines and different colors 
indicate aliphatic resonances corresponding to the same residue, correlated to their own HN. 
Assignments (in black) were obtained with the help of a 1H-1H NOESY spectrum acquired in 
analogous conditions. Horizontal bands indicate regions of the spectrum gathering particular 
resonance types. On the right panel, a region of the 1H-13C HSQC spectrum is shown displaying 
the Hα-Cα region, including assignments. (b) 13C secondary chemical shifts were determined 
through the assignment of Cα and Cβ resonances in a series of 1H-13C HSQC spectra at the 
indicated pH values, with assignments assisted by the 1H-1H TOCSY and NOESY pairs at each 
pH value. Small ΔδCα – ΔδCβ in the ±1 ppm range are compatible with a polyproline II secondary 
structure. A random coil-a-helix-b-sheet equilibrium, which would yield similar values, can be 
ruled out considering CD data. Methionine 3 Cα chemical shifts could not be measured as the 
signal is masked behind the water signal along the titration. (c) The pKa values of the carboxylic 
groups at the side-chains of Glu and Asp residues in the peptide were determined by monitoring 





2.4. Characterization of peptides synthesized 
 
Figure S25. HPLC chromatograms (left) of (a) αSP, (b) αSPN, and (c) αSPC and their MS spectra 
















Figure S28. HPLC chromatogram (left) of 6EN (CEEEEEE-NH2) and its MS spectra (right) 
















Figure S30. HPLC chromatograms (left) and MS spectra (right) obtained from the main peak of 






Figure S31. HPLC chromatograms (left) of (a) (tdm)αSP, (b) (tdm)αSPN, and (c) (tdm)αSPC and their 







Figure S32. HPLC chromatograms (left) of (a) (P￫A)αSPN, (b)(Y￫A)αSPN, and (c) (P/Y￫A)αSPN and 
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